• Multiple Chemical Sensitivity Syndrome As Inadmissable Junk Science
  • April 20, 2006 | Author: Brian P. Heermance
  • Law Firms: Morrison Mahoney LLP - New York Office; Morrison Mahoney LLP - Boston Office
  • Multiple Chemical Sensitivity Syndrome ("MCSS") is a catch all phrase that has gained attention in recent years and has been claimed in many personal injury law suits. Fortunately, under the Supreme Court's standards in Daubert v. Dow Chemical and Frye v. United States, the potential that expert testimony regarding MCSS will be deemed admissible at trial remains slight.